AlphaYouNGNE: McMinn Rachel discloses securities transactions
By AlphaYouPublished Form 4
McMinn Rachel
Reporting filer
McMinn Rachel reported Exercise or conversion in Neurogene Inc.: 756 units of Common Stock, dated 2026-09-22. The full Form 4 contains 2 transaction entries.
- Disclosed
- Oct 2, 2026
Reported details
2 entries| Security | Owner | Date | Code | Action | Quantity | Price | Following holdings | Reporting delay | Filed terms and references |
|---|---|---|---|---|---|---|---|---|---|
| Common Stock | McMinn Rachel | 2026-09-22 | M | Exercise or conversion | 756 | 25.32 | 1,345,063 | 10 days | Filed terms
|
| Stock Option (Right to Buy) (derivative) | McMinn Rachel | 2026-09-22 | M | Exercise or conversion | 756 | 0 | 0 | 10 days | Filed terms
|
Common Stock
- Owner
- McMinn Rachel
- Date
- 2026-09-22
- Code
- M
- Action
- Exercise or conversion
- Quantity
- 756
- Price
- 25.32
- Following holdings
- 1,345,063
- Reporting delay
- 10 days
- Filed terms and references
Filed terms
- security Title: Common Stock
- transaction Date: 2026-09-22
- transaction Form Type: 4
- transaction Code: M
- equity Swap Involved: 0
- transaction Shares: 756
- transaction Price Per Share: 25.32
- transaction Acquired Disposed Code: A
- shares Owned Following Transaction: 1345063
- id: F1
- direct Or Indirect Ownership: D
Stock Option (Right to Buy) (derivative)
- Owner
- McMinn Rachel
- Date
- 2026-09-22
- Code
- M
- Action
- Exercise or conversion
- Quantity
- 756
- Price
- 0
- Following holdings
- 0
- Reporting delay
- 10 days
- Filed terms and references
Filed terms
- security Title: Stock Option (Right to Buy)
- conversion Or Exercise Price: 25.32
- transaction Date: 2026-09-22
- transaction Form Type: 4
- transaction Code: M
- equity Swap Involved: 0
- transaction Shares: 756
- transaction Price Per Share: 0
- transaction Acquired Disposed Code: D
- id: F2
- expiration Date: 2026-09-22
- underlying Security Title: Common Stock
- underlying Security Shares: 756
- shares Owned Following Transaction: 0
- direct Or Indirect Ownership: D
Purchases, sales, grants and option exercises are different transactions. The reported code identifies the action; it does not establish a motive.
Filing context
- Quantities and prices are shown in the units filed. No trade value is inferred from their product.
- McMinn Rachel: Chief Executive Officer, Director.
- F1: Includes (a) 15,933 restricted stock units that vest annually in equal installments on March 23, 2027 and March 23, 2028; and (b) 25,900 restricted stock units that vest annually in equal installments on February 20, 2027, February 20, 2028 and February 20, 2029.
- F2: This option is fully vested and exercisable.
Original sources
Prepared automatically from public filing data. Report a correction.